IP Library Granted Patent US 9,606,126
Granted Patent B2
US 9,606,126 · App. 13/376,729 · Granted Mar 28, 2017

Compositions and methods for membrane protein detergent stability screen

Inventors: Michael C. Wiener (Charlottesville, VA); James M. Vergis (Gaithersburg, MD)
Assignee: University of Virgina Patent Foundation
G01N33/6803C30B7/08B01D15/3804
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,606,126
App. No.
13/376,729
Granted
Mar 28, 2017
Kind
B2
Abstract

The invention provides methods to assess protein stability and to obtain sizing information. In one aspect, the screen comprises a 94 detergent panel and a series of MWCO filtered microplates. A protein of interest is bound to an affinity matrix and aliquoted into a 96-well microplate. Wells containing the immobilized protein are washed in the new detergent and then eluted in the new detergent into a collection plate. Protein not stable in the new detergent is precipitated on the resin and not present in the elutions. Half of the elution is passed through a high (i.e., 300 kDa) MWCO microplate and the other half through a low (i.e., 100 kDa) MWCO microplate. Elutions from the microplates are spotted on a nitrocellulose membrane, visualized by Western analysis (or by some other method), and quantified. The high MWCO provides stability readout and the ratio of low/high kDa provides sizing information.

Claims (443)

1. A method for determining the stability and size of a protein in at least one detergent using a rapid differential filtration detergent screening assay, said method comprising:

a) obtaining a solution comprising said protein in a first detergent;

b) adding an effective amount of an affinity resin to said solution;

c) adding an aliquot of said solution comprising said protein in a first detergent and an affinity resin to a first chamber, said first chamber comprising a filter wherein said pore size is about 0.2 μm;

d) washing said first chamber with a wash solution comprising a different detergent wherein the concentration of said different detergent is the critical micelle concentration of said different detergent;

e) eluting said protein in said first chamber with an elution solution comprising said different detergent and collecting the eluate;

f) passing an aliquot of said eluate through a second chamber comprising a high molecular weight cut-off filter and another aliquot of said eluate through a third chamber comprising a low molecular weight cut-off filter;

g) measuring the amount of protein in the eluate passing through the high molecular weight cut-off filter and the amount of protein in the eluate passing through the low molecular weight cut-off filter; and

h) comparing the amount of protein eluted through the high molecular weight cut-off filter with the amount of protein eluted through the low molecular weight cut-off filter, thereby determining the stability and size of a protein in at least one detergent using a rapid differential filtration detergent screening assay.

2. The method of claim 1 , wherein said first chamber is a well of a multiwell microplate.

3. The method of claim 1 , wherein said second chamber is a well of a multiwell microplate, further wherein each well comprises a high molecular weight cut-off filter.

4. The method of claim 1 , wherein said third chamber is a well of a multiwell microplate, further wherein each well comprises a low molecular weight cut-off filter.

5. The method of claim 2 , wherein at least two wells are used.

6. The method of claim 5 , wherein the first detergent in step a) is tested with multiple different detergents in step d), wherein a different first well is used for each of said multiple different detergents tested and optionally one or more wells comprise a positive control and one or more wells comprise a negative control.

7. The method of claim 6 , wherein when multiple detergents are tested, each well comprising a detergent comprises a different detergent than the other wells comprising a detergent, and optionally one or more wells comprise a positive control and one or more wells comprise a negative control.

8. The method of claim 1 , wherein said high molecular weight cut-off filter is about 300 kDa.

9. The method of claim 1 , wherein said low molecular weight cut-off filter is about 100 kDa.

10. The method of claim 7 , wherein said multiwell plate is a 96, 384, or 1536 well plate.

11. The method of claim 10 , wherein said 96 well plate is a Society for Biomolecular Sciences format plate.

12. The method of claim 10 , wherein 94 different detergents are tested.

13. The method of claim 1 , wherein said different detergent and said different detergents concentration is selected from the following table:

[Det]

Well

Abbrev.

Name

mM

A1

A2

A3

Z3-12

n-Dodecyl-N,N-dimethyl-3-ammonio-1-

(2.8)

propanesulfonate

A4

Z3-14

-n-Tetradecyl-N,N-dimethyl-3-ammonio-

(0.2)

1-propanesulfonate

A5

DMG

n-Decyl-N,N-dimethylglycine

(19)

A6

DOMG

n-Dodecyl-N,N-dimethylglycine

(1.5)

A7

DAO

n-Decyl-N,N-dimethylamine-N-oxide

(10.5)

A8

UDAO

n-Undecyl-N,N,-dimethylamine-N-oxide

(3.2)

A9

LDAO

n-Dodecyl-N,N-dimethylamine-N-oxide

(1)

A10

C-DDFOS

Cyclododecyl-1-phosphocholine

(22)

A11

CF-4

4-Cyclohexyl-1-butylphosphocholine

(14)

A12

CF-5

5-Cyclohexyl-1-pentylphosphocholine

(4.5)

B1

CF-6

6-Cyclohexyl-1-hexyphosphocoline

(2.68)

B2

CF-7

7-Cyclohexyl-1-heptylphosphocholine

(0.62)

B3

FC-10

n-Decylphosphocholine

(11)

B4

FC-11

n-Undecylphosphocholine

(1.85)

B5

FC-12

n-Dodecylphosphocholine

(1.5)

B6

FC-13

n-Tridecylphosphocholine

(0.75)

B7

FC-14

n-Tetradecylphosphocholine

(0.12)

B8

FC-I11

2,8-Dimethyl-5-nonylphosphocholine

(26.6)

B9

FC-I11-6U

Undecyl-6-phosphocholine

(25.8)

B10

FC-I9

2,6-Dimethyl-4-heptylphosphocholine

(32)

B11

FC-U10-11

10-Undecylenyl-1-phosphocholine

(6.2)

B12

DHPC

1,2-Diheptanoyl-sn-glycero-3-

(1.4)

phosphocholine

C1

LPC-10

1-Decanoyl-2-hydroxy-sn-glycero-3-

(8)

phosphocholine

C2

LPC-12

1-Lauroyl-2-hydroxy-sn-glycero-3-

(0.7)

phosphocholine

C3

FOSFEN-9

Nonylphenylphosphocholine

(1.35)

C4

CHAPS

3-[(3-Cholamidopropyl)dimethylamminio]-

(8)

1-propanesulfonate

C5

CHAPSO

3-[(3-Cholamidopropyl)dimethylamminio]-

(8)

2-hydroxy-1-propanesulfonate

C6

DDMAU

n-Dodecyl-N,N-

(0.13)

(dimethylammonio)undecanoate

C7

DDMAB

n-Dodecyl-N,N-(dimethylammonio)butyrate

(4.3)

C8

LAPAO

3-Dpdecylamido-N,N′-dimethylpropyl

(1.6)

amine oxide

C9

TRIPAO

3-(3 Butyl-3-phenylheptanamido)-N,N-

(4.5)

dimethylpropan-1-amine oxide

C10

T-20

Polyoxyethylene(20) sorbitane monolaurate

(0.059)

C11

BRIJ-35

Polyoxyethylene lauryl ether

(0.091)

C12

TX-100

Tetramethylbutyl)phenyl]-ω-hydroxy-

(0.23)

poly(oxy-1,2-ethanediyl), average MW 647

D1

TX-114

Teteamethylbutyl)phenyl]-ω-hydroxy-

(0.2)

poly(oxy-1,2-ethanediyl), average MW 536

D2

TX-305

Teteamethylbutyl)phenyl]-ω-hydroxy-

(0.65)

poly(oxy-1,2-ethanediyl),

average MW 1526

D3

TX-405

Teteamethylbutyl)phenyl]-ω-hydroxy-

(0.81)

poly(oxy-1,2-ethanediyl),

average MW 1967

D4

NID-P40

[Octylphenoxy]polyethoxyethanol

(0.3)

D5

APO8

Dimethyloctylphosphine oxide

(40)

D6

APO9

Dimethylnonylphosphine oxide

(10)

D7

APO10

Dimethyldecylphosphine oxide

(4.66)

D8

APO11

Dimethylundecylphosphine oxide

(1.2)

D9

APO12

Dimethyldodecylphosphine oxide

(0.57)

D10

C6E3

Triethylene glycol monohexyl ether

(23)

D11

C6E4

Tetraethylene glycol monohexyl ether

(30)

D12

C6E5

Pentaethylene glycol monohexyl ether

(37)

E1

C7E5

Pentaethylene glycol monoheptyl ether

(21)

E2

C8E4

Tetraethylene glycol monooctyl ether

(8)

E3

C8E5

Pentaethylene glycol monooctyl ether

(7.1)

E4

C8E6

Hexaethylene glycol monooctyl ether

(10)

E5

C10E5

Pentaethylene glycol monodecyl ether

(0.81)

E6

C10E6

Hexaethylene glycol monodecyl ether

(0.9)

E7

C10E9

Polyoxyethylene(9)decyl ether

(1.3)

E8

C12E8

Octaethylene glycol monododecyl ether

(0.09)

E9

C12E9

Polyoxyethylene(9)dodecyl ether

(0.05)

E10

C12E10

Polyoxyethylene(10)dodecyl ether

(0.2)

E11

C13E8

Polyoxyethylene(8)tridecyl ether

(0.1)

E12

CHAP

N,N′-bis-(3-D-

(2.9)

Gluconamidopropyl)cholamide

F1

CHAP-D

N,N′-bis-(3-D-

(1.4)

Gluconamidopropyl)deoxycholamide

F2

OHES

Octyl-2-hydroxyethyl-sulfoxide

(24.2)

F3

RDHPOS

Rac-2,3-dihydroxypropyloctylsulfoxide

(24.2)

F4

GX-100

Polyoxyethylene(10) Isotridecyl Ether

(0.15)

F5

HTG

n-Heptyl-β-D-thioglucopyranoside

(29)

F6

OG

n-Octyl-β-D-glucopyranoside

(18)

F7

NG

n-Nonyl-β-D-glucopyranoside

(6.5)

F8

CYGLU-3

3-Cyclohexyl-1-propyl-β-D-glucoside

(28)

F9

HECAMEG

Methyl-6-O-(N-heptylcarbamoyl)-α-D-

(19.5)

glucopyranoside

F10

HEGA-9

Nonanoyl-N-hydroxyethylglucamide

(39)

F11

C-HEGA-10

Cyclohexylbutanoyl-N-

(35)

hydroxyethylglucamide

F12

C-HEGA-11

Cyclohexylbutanoyl-N-

(11.5)

hydroxyethylglucamide

G1

CYMAL-3

3-Cyclohexyl-1-propyl-β-D-maltoside

(30)

G2

CYMAL-4

4-Cyclohexyl-1-butyl-β-D-maltoside

(7.6)

G3

CYMAL-5

5-Cyclohexyl-1-pentyl-β-D-maltoside

(2.4)

G4

CYMAL-6

6-Cyclohexyl-1-hexyl-β-D-maltoside

(0.56)

G5

CYMAL-7

7-Cyclohexyl-1-heptyl-β-D-maltoside

(0.19)

G6

DMHM

2,6-Dimethyl-4-heptyl-β-D-maltoside

(27.5)

G7

OM

n-Octyl-β-D-maltopyranoside

(19.5)

G8

NM

n-Nonyl-β-D-maltopyranoside

(6)

G9

DαM

n-Decyl-α-D-maltopyranoside

(1.6)

G10

DM

n-Decyl-β-D-maltopyranoside

(1.8)

G11

UDαM

n-Undecyl-α-D-maltopyranoside

(0.58)

G12

UDM

n-Undecyl-β-D-maltopyranoside

(0.59)

H1

ωUDM

ω-Undecylenyl-β-D-maltopyranoside

(1.2)

H2

DDαM

n-Dodecyl-α-D-maltopyranoside

(0.15)

H3

DDM

n-Dodecyl-β-D-maltopyranoside

(0.17)

H4

TDM

n-Tridecyl-β-D-maltopyranoside

(0.03)

H5

OTM

n-Octyl-β-D-thiomaltopyranoside

(8.5)

H6

NTM

n-Nonyl-β-D-thiomaltopyranoside

(3.2)

H7

DTM

n-Decyl-β-D-thiomaltopyranoside

(0.9)

H8

UDTM

n-Undecyl-β-D-thiomaltopyranoside

(0.21)

H9

DDTM

n-Dodecyl-β-D-thiomaltopyranoside

(0.05)

H10

S-8

n-Octanoyl-β-D-fructofuranosyl-α-D-

(24.4)

glucopyranoside

H11

S-10

α-D-Glucopryanoside, β-D-

(2.5)

Fructofuranosyl Monodecanoate

H12

S-12

n-Monododecanoate-α-D-

(0.3)

glucopyranoside, β-D-Fructofuranosyl.

14. The method of claim 1 , wherein said solution comprising said protein in a first detergent comprises about 1000 micrograms or less of said protein.

15. The method of claim 1 , wherein said solution comprising said protein in a first detergent comprises about 500 micrograms or less of said protein.

16. The method of claim 1 , wherein said solution comprising said protein in a first detergent comprises about 400 micrograms or less of said protein.

17. The method of claim 1 , wherein said solution comprising said protein in a first detergent comprises about 200 micrograms or less of said protein.

18. The method of claim 1 , wherein said solution comprising said protein in a first detergent comprises about 100 micrograms or less of said protein.

19. The method of claim 1 , wherein said solution comprising said protein in a first detergent comprises about 50 micrograms or less of said protein.

20. The method of claim 1 , wherein said method is performed in less than about two hours.

21. The method of claim 1 , wherein said method is performed in less than about 1 hour.

22. The method of claim 1 , wherein said protein amounts are determined by dot blot or Western blot analysis.

23. The method of claim 22 , wherein said protein amounts determined from the high molecular weight cut-off dot blots are normalized and plotted with the ratio of low:high normalized intensities and the values grouped into quartiles.

24. The method of claim 22 , wherein said protein amounts determined from the high molecular weight cut-off dot blots are normalized and plotted graphically on the abscissa while the ratio of low:high normalized intensities are plotted on the ordinate.

25. The method of claim 1 , further wherein said method is used to screen detergent mixtures, additives, ionic strength, and pH.

26. The method of claim 1 , wherein said protein is a membrane protein.

27. The method of claim 1 , wherein said different detergent has zwitterionic or nonionic headgroups.

28. The method of claim 1 , wherein at least one of said first, second, or third chambers is subjected to centrifugation to enhance the filtration process.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jan 24, 2012
From: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027580/0895 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2011
From: UNIVERSITY OF VIRGINIA
To: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
Reel/Frame 027347/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2011
From: WIENER, MICHAEL C.; VERGIS, JAMES M.
To: UNIVERSITY OF VIRGINIA
Reel/Frame 027352/0378 →
Continuity (2)
Provisional Application 61221198 · Jun 29, 2009
Related Publication 20120108463A1 · May 3, 2012